Overview Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome Status: Terminated Trial end date: 2015-01-01 Target enrollment: Participant gender: Summary The main objective of this study is to evaluate efficacy and safety of ALS-L1023 tablet in patients with abdominal obesity of metabolic syndrome. Phase: Phase 3 Details Lead Sponsor: Hanmi Pharmaceutical Company Limited